Pharmaceutical Name
Feline Leukemia Vaccine, Killed Virus

• One of the most thoroughly tested, fully researched FeLV vaccines on the market.

• Independent research documents highly effective protection against persistent viremia, and latent infections.

• Study shows 83% protection against any viremia.

• Documented 1-year duration of immunity challenge study.

• Helps protect against lymphoid tumors caused by Feline Leukemia Virus infection.

• IM or SQ administration.

Indications
FEVAXYN FeLV^® is recommended for the vaccination of healthy cats as an aid in the prevention of disease associated with feline leukemia virus infection. Vaccination with the product prevents persistent viremia in cats exposed to virulent feline leukemia virus.

Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
 
Fevaxyn FeLV^® is a registered trademark of Schering-Plough Animal Health Corporation.